Profile avatar
sitcancer.bsky.social
The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.
50 posts 629 followers 333 following
Prolific Poster

The Spring Scientific is almost here and will take place on March 12–14, 2025. #SITC will bring the brightest minds and next generation of leaders together to explore promising #science and develop novel opportunities to address these challenges. Register: go.sitcancer.org/4fupoc0

Apply now for a one-year, $100,000 SITC Diversity, Equity and Inclusion Fellowship. Letter of Intent due on March 12. #SITCFellowship #ECR sitcancer.org/sitc2025

So excited for @sitcancer.bsky.social #ACI #WomensMalignancies that is about to start 11am EST

Dr. Gatti-Mays, we are looking forward to the engaging conversations and important insights at today’s #ACI #WomensMalignancies program! Join @drgattimays.bsky.social and a panel of clinical experts at 11am EST! #oncSky #CanSky

New Journal for ImmunoTherapy of Cancer ( #JITC ) short report: Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors bit.ly/43bFMuy @jasonlukemd.bsky.social @news.upmc.com @djpinato.bsky.social #OncSky #CanSky #research

Incredible to see how much you’ve grown in the #immunotherapy field! We are glad the SITC community — from our leaders to your fellow #Sparkathon alumni and everyone you’ve met along the way could play a part in your evolution!

Proud to share our @nature.com paper, co-led by Chadi El Farran & Charles Couturier under mentorship of Brad Bernstein where we develop a new framework to understand immunomodulatory myeloid cells in #glioma & lay a foundation to develop more effective immunotherapies. www.nature.com/articles/s41...

We are proud to support your amazing work in immunomodulatory myeloid cells in glioma!

The TRCCC-SITC collab session on "Cell Therapy for Solid Tumor" was a stellar gathering of groundbreaking research! Congrats to the recipients of the SITC Travel Awards for Best Junior Faculty Presentation: -Kathleen Houlahan, PhD, McMaster Univ -Rebecca Obeng, MD, PhD, Case CCC #MedSky #OncSky

Calling all early career professionals interested in transitioning into a career in biotech. SITC is offering free webinars on March 3, 10 a.m. CST & March 27, 3 p.m. CST. Register today to connect with a panel of experts in the field! sitcancer.org/biotech-virtual-programs#webinars

Early career investigators! Apply now for a one-year, $100,000 SITC - Merck Cancer Immunotherapy Clinical Fellowship! Letter of Intent due on March 12. #SITCFellowship #ECR sitcancer.org/merck2025

#SITC #WIN 2025 features presentations by experienced female leaders from the #IO field. The program includes panel discussions to ask questions and interact with these leaders and networking opportunities. Apply by March 24, 2025. www.sitcancer.org/professional...

New Journal for ImmunoTherapy of Cancer ( #JITC ) article: Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer bit.ly/3ET6xtD @fstrozzi.bsky.social @wickwolfgang.bsky.social

Register for SITC’s free webinar series and learn from a panel of IO professionals in biotech. The Clinical Development Career Path Webinar is on March 3 10 a.m. CST. Followed by the Research and Development Career Path Webinar on March 27 3 p.m. CST. sitcancer.org/biotech-virtual-programs#webinars

Apply to the Lunit research program to access Lunit SCOPE IO for quantitative immune phenotyping, TIL, and TME analysis from H&E WSIs. This program is exclusively for SITC members! Apply by April 30. Learn more: sitcancer.org/lunit

Early career investigators! Apply now for a one-year, $100,000 SITC - Genmab Cancer Immunotherapy in Hematologic Malignancies: DLBCL, FL, and CLL Translational Fellowship! Letter of Intent due on March 12 #ECR sitcancer.org/Genmab2025

Join 10 clinical IO experts Feb. 28 at SITC’s Women’s Malignancies program! Advance your clinical knowledge and dive into the latest FDA-approved treatment options. Earn free CME credit with a cutting-edge learning opportunity. Learn more: www.sitcancer.org/education/ac... #MedSky #OncSky #CanSky

SITC is excited to share the 2024 Year in Review! Discover the breadth and depth of programming from last year! Learn more: www.sitcancer.org/yearinreview... #IO #SITCQuestfor100

Domestic and international early career investigators in academia or government: submit a Letter of Intent (LOI) by March 12 for SITC Fellowship Awards totaling $300,000! Learn more and submit your application(s) at sitcancer.org/fellowships #SITCFellowship #IO #grant #funding

Looking to push your career to the next level? Register for free, SITC’s Clinical Development Career Path Webinar on March 3 at 10 a.m. CST. Learn from a panel of experts and have the opportunity to ask questions throughout the discussion. #IO #Biotech sitcancer.org/biotech-virtual-programs#webinars

Optimize patient screening with an expert learning opportunity! SITC’s ACI: A Focus on Toxicity Management program outlines best practices for multidisciplinary management of patients receiving cancer IO treatment. Join March 7 for a free #CME program: ow.ly/5hhu50V3xOF @tiansterzhangmd.bsky.social

The #SITC Women in Cancer Immunotherapy Network Leadership Institute is an initiative seeking to promote and elevate women in the cancer immunotherapy field. Two options to apply for: Aug. 7–8, 2025 in Chicago, IL or virtually Sept. 15–16, 2025. Apply by March 24! www.sitcancer.org/professional...

Annual @sitcancer.bsky.social crew picture at #TRCCC 2025 @immunegirl.bsky.social @ Michelle Williams and Sarah Gitto

As more discoveries and breakthroughs occur, more efforts are needed to develop and advance strategies of immunotherapy for the treatment of brain cancers. Dr. Vitanza, we are grateful for your participation in these important discussions!

NOW AVAILABLE: SITC Fellowships totaling $300,000 in funding! SITC is calling early career investigators looking for potential funding opportunities to apply with a Letter of Intent. Learn more about the application process here: sitcancer.org/fellowships #SITCFellowship #IO #grant #funding

Stay informed on the latest research in cancer immunotherapy with the Feb. issue of the #JITC Digest! Check out two complete special series: "Cancer Immunotherapy in Understudied Populations" and "Computational I-O". Don’t miss these highlights and more: ow.ly/UX9V50V2WLJ #research #cancer

New Journal for ImmunoTherapy of Cancer ( #JITC ) article: CD56bright cytokine-induced memory-like NK cells and NK-cell engagers synergize against non-small cell lung cancer cancer-stem cells bit.ly/4b1H4tK #lungcancer #research #OncSky #science #MedSky

Huge congratulations to @megen-w.bsky.social on being awarded the NCI F30 grant! This is a well-deserved recognition and we wish you continued success🎉🎉🎉

New Journal for Immunotherapy of Cancer ( #JITC ) article: Sex and outcomes of patients with microsatellite instability-high and BRAF V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors bit.ly/4129fEz @sundarraghav.bsky.social #OncSky #research #cancer

SITC's FREE virtual Neuro Immuno-Oncology Summit will be an impactful event. Dive into important discussions and learn from an expert lineup of speakers! Thank you Dr. Gartrell and the amazing team behind this program🎉🎉🎉 #medSky #OncSky #neuro

Fellowship opportunities open Feb. 19! Preview the available opportunities now, and discover the new application process consisting of two stages. SITC Fellowships are only available to SITC members! sitcancer.org/fellowships #SITCFellowship #IO #immunotherapy #grant #funding

Excellent talk by Dr. Zach Buchwald @zach-buchwald.bsky.social from @winshipatemory.bsky.social on immunotherapy in special patient populations. Talks about his amazing work on brain meta and circadian rhythm in immunity!! #CIWS2025 @sitcancer.bsky.social

New Journal for ImmunoTherapy of Cancer ( #JITC ) article: Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionality t.co/cosmz4Z6xk #research #science #OncSky #MedSky #stem

We are hiring a Project Coordinator at @sitcancer.bsky.social SITC - Check out the job description and share with those looking to get their feet wet in journal operations and some entry level project management experience. bit.ly/3Qf6GKj #jobopening

Great talk by Dr. Gregory Lesinski @lesinskilab.bsky.social @winshipatemory.bsky.social on how to get predictive biomarkers in every clinical trial @sitcancer.bsky.social #CIWS2025

SITC is offering two free webinars focusing on how to land the right position in biotech. Hosted on March 3 at 10 a.m. CST and March 27 at 3 p.m. CST. Register today to learn about how to enter the clinical development and research & development tracks! sitcancer.org/education/bi... #biotech

SITC is deeply concerned by the announcement from NIH that will cut billions of dollars in indirect costs. We urge the NIH & the new administration to reverse this action to ensure life-saving cancer treatments continue to reach the clinic and patients. sitcancer.org/advocacy/ind...

SITC’s Cancer Immunotherapy Winter School is buzzing from the insights shared by Dr. Paulos! Thank you for sharing your expertise and passion! @chrystalpaulos.bsky.social #CIWS2025 #CD4

New Journal for ImmunoTherapy of Cancer ( #JITC )article: Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma bit.ly/4hTppa7 #MedSky #research #science #NCI #OncSky #CanSky

Dr. Yina Huang brings the house down with her AMAZING talk on harnessing synthetic biology to augment next generation cell therapy for cancer patients at Winter School @sitcancer.bsky.social 💥

💥 Dr. Greg Lesinski @lesinskilab.bsky.social @sitcancer.bsky.social gives an outstanding talk on harnessing combination immunotherapies in preclinical models to guide new clinical trials for patients. #CIWS2025 @sitcancer.bsky.social 💥

B cell guru and talented cancer immunotherapist Dr. Tullia Bruno at UPitt delivers an inspiring talk at Winter School today in Austin! 💥 @sitcancer.bsky.social

Discuss real-world case studies with clinical experts! #SITC’s ACI: Women’s Malignancies program will explore practical insights to apply immunotherapy into clinical practice. Join Feb. 28 for a free CME program. Register now: ow.ly/bTFn50UYy9j @drgattimays.bsky.social @veredstearns.bsky.social

Dr. Sumit Subudhi talks about a patient who picked this new therapy called anti-CTLA4 therapy over going to hospice. He was cured of melanoma! @sitcancer.bsky.social m #CIWS2025 Winter school. Cancer research advances medicine and gives more days to life!!!

Excellent talk by trailblazer Dr. Dan Powell @pennmedicine.bsky.social on adoptive immunotherapy and CAR T cells!@l @sitcancer.bsky.social #CIWS2025 Winter school in Austin.

We’re thrilled to welcome Dr. Perrine Verdys and Shawez Khan from Denmark and Moldir Konysbekova from Kazakhstan to our 2025 Cancer Immunotherapy Winter School program. Thanks to all the attendees that made the trip to Austin! #CIWS2025

Wonder virtual talk by the one and only Dr Greg Delgoffe @delgoffelab.bsky.social on the immunosuppression in the tumor we must understand and battle to make a difference in our patients! #CIWS2026 @sitcancer.bsky.social